279 related articles for article (PubMed ID: 32412785)
1.
Koppinger MP; Lopez-Pier MA; Skaria R; Harris PR; Konhilas JP
Am J Physiol Heart Circ Physiol; 2020 Jul; 319(1):H32-H41. PubMed ID: 32412785
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic Supplementation with Lactobacillus Reuteri or Its Metabolite GABA Protects Against Acute Ischemic Cardiac Injury.
Wang J; Zhang H; Yuan H; Chen S; Yu Y; Zhang X; Gao Z; Du H; Li W; Wang Y; Xia P; Wang J; Song M
Adv Sci (Weinh); 2024 May; 11(18):e2307233. PubMed ID: 38487926
[TBL] [Abstract][Full Text] [Related]
3. Lactobacillus reuteri A9 and Lactobacillus mucosae A13 isolated from Chinese superlongevity people modulate lipid metabolism in a hypercholesterolemia rat model.
Jiang J; Feng N; Zhang C; Liu F; Zhao J; Zhang H; Zhai Q; Chen W
FEMS Microbiol Lett; 2019 Dec; 366(24):. PubMed ID: 31855230
[TBL] [Abstract][Full Text] [Related]
4. Effects of hypercholesterolemia on myocardial ischemia-reperfusion injury in LDL receptor-deficient mice.
Girod WG; Jones SP; Sieber N; Aw TY; Lefer DJ
Arterioscler Thromb Vasc Biol; 1999 Nov; 19(11):2776-81. PubMed ID: 10559025
[TBL] [Abstract][Full Text] [Related]
5. Lactobacillus reuteri mitigates hepatic ischemia/reperfusion injury by modulating gut microbiota and metabolism through the Nrf2/HO-1 signaling.
Zhang L; Gong X; Tan J; Zhang R; Li M; Liu C; Wu C; Li X
Biol Direct; 2024 Mar; 19(1):23. PubMed ID: 38500127
[TBL] [Abstract][Full Text] [Related]
6. FXR Signaling-Mediated Bile Acid Metabolism Is Critical for Alleviation of Cholesterol Gallstones by
Ye X; Huang D; Dong Z; Wang X; Ning M; Xia J; Shen S; Wu S; Shi Y; Wang J; Wan X
Microbiol Spectr; 2022 Oct; 10(5):e0051822. PubMed ID: 36036629
[TBL] [Abstract][Full Text] [Related]
7. Lactobacillus reuteri F-9-35 Prevents DSS-Induced Colitis by Inhibiting Proinflammatory Gene Expression and Restoring the Gut Microbiota in Mice.
Sun MC; Zhang FC; Yin X; Cheng BJ; Zhao CH; Wang YL; Zhang ZZ; Hao HW; Zhang TH; Ye HQ
J Food Sci; 2018 Oct; 83(10):2645-2652. PubMed ID: 30216448
[TBL] [Abstract][Full Text] [Related]
8. Cholesterol-lowering efficacy of a microencapsulated bile salt hydrolase-active Lactobacillus reuteri NCIMB 30242 yoghurt formulation in hypercholesterolaemic adults.
Jones ML; Martoni CJ; Parent M; Prakash S
Br J Nutr; 2012 May; 107(10):1505-13. PubMed ID: 22067612
[TBL] [Abstract][Full Text] [Related]
9. Oral supplementation with probiotic L. reuteri NCIMB 30242 increases mean circulating 25-hydroxyvitamin D: a post hoc analysis of a randomized controlled trial.
Jones ML; Martoni CJ; Prakash S
J Clin Endocrinol Metab; 2013 Jul; 98(7):2944-51. PubMed ID: 23609838
[TBL] [Abstract][Full Text] [Related]
10. Effect of Antiobiotic-Induced Disbiosis and Its Correction with Probiotics on Myocardial Tolerance to Ischemia-Reperfusion Injury in SPF Rats.
Borshchev YY; Sinitsa AV; Zakharchenko MM; Borshchev VY; Burovenko IY; Galagudza MM
Bull Exp Biol Med; 2019 Feb; 166(4):440-443. PubMed ID: 30788733
[TBL] [Abstract][Full Text] [Related]
11. Supplementary heat-killed Lactobacillus reuteri GMNL-263 ameliorates hyperlipidaemic and cardiac apoptosis in high-fat diet-fed hamsters to maintain cardiovascular function.
Ting WJ; Kuo WW; Kuo CH; Yeh YL; Shen CY; Chen YH; Ho TJ; Viswanadha VP; Chen YH; Huang CY
Br J Nutr; 2015 Sep; 114(5):706-12. PubMed ID: 26234728
[TBL] [Abstract][Full Text] [Related]
12. Hypocholesterolemic Effects of Probiotic Mixture on Diet-Induced Hypercholesterolemic Rats.
Kim SJ; Park SH; Sin HS; Jang SH; Lee SW; Kim SY; Kwon B; Yu KY; Kim SY; Yang DK
Nutrients; 2017 Mar; 9(3):. PubMed ID: 28300786
[TBL] [Abstract][Full Text] [Related]
13. The beneficial effects of Lactobacillus reuteri ADR-1 or ADR-3 consumption on type 2 diabetes mellitus: a randomized, double-blinded, placebo-controlled trial.
Hsieh MC; Tsai WH; Jheng YP; Su SL; Wang SY; Lin CC; Chen YH; Chang WW
Sci Rep; 2018 Nov; 8(1):16791. PubMed ID: 30429496
[TBL] [Abstract][Full Text] [Related]
14. Hypocholesterolemic effects of Lactobacillus reuteri LR6 in rats fed on high-cholesterol diet.
Singh TP; Malik RK; Katkamwar SG; Kaur G
Int J Food Sci Nutr; 2015 Feb; 66(1):71-5. PubMed ID: 25265203
[TBL] [Abstract][Full Text] [Related]
15.
Liu Y; Tian X; He B; Hoang TK; Taylor CM; Blanchard E; Freeborn J; Park S; Luo M; Couturier J; Tran DQ; Roos S; Wu G; Rhoads JM
Am J Physiol Gastrointest Liver Physiol; 2019 Dec; 317(6):G824-G838. PubMed ID: 31482733
[TBL] [Abstract][Full Text] [Related]
16. Limosilactobacillus reuteri consumption significantly reduces the total cholesterol concentration without affecting other cardiovascular disease risk factors in adults: A systematic review and meta-analysis.
Liu J; Zhu R; Song J; Sohaib M; Wang S; Mao J; Qi J; Xiong X; Zhou W; Guo L
Nutr Res; 2023 Sep; 117():1-14. PubMed ID: 37419064
[TBL] [Abstract][Full Text] [Related]
17. Multidisciplinary and Comparative Investigations of Potential Psychobiotic Effects of
Beck BR; Park GS; Jeong DY; Lee YH; Im S; Song WH; Kang J
Front Cell Infect Microbiol; 2019; 9():269. PubMed ID: 31404163
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the anti-inflammatory Lactobacillus reuteri BM36301 and its probiotic benefits on aged mice.
Lee J; Yang W; Hostetler A; Schultz N; Suckow MA; Stewart KL; Kim DD; Kim HS
BMC Microbiol; 2016 Apr; 16():69. PubMed ID: 27095067
[TBL] [Abstract][Full Text] [Related]
19. Effect of Lactobacillus acidophilus NS1 on plasma cholesterol levels in diet-induced obese mice.
Song M; Park S; Lee H; Min B; Jung S; Park S; Kim E; Oh S
J Dairy Sci; 2015 Mar; 98(3):1492-501. PubMed ID: 25468703
[TBL] [Abstract][Full Text] [Related]
20. [Influence of Lactobacillus reuteri SL001 on intestinal microbiota in AD model mice and C57BL/6 mice].
Liu M; Hu R; Guo Y; Sun W; Li J; Fan M; Wang Y; Du H; Tang Z; Chai C
Sheng Wu Gong Cheng Xue Bao; 2020 Sep; 36(9):1887-1898. PubMed ID: 33164464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
